Skip to main content

Israel M. Barbash, MD

Original Contribution
05/21/2014
A comparison of the long-term safety and clinical effectiveness of the Xience V everolimus-eluting stent to both the Taxus paclitaxel-eluting stent and the Cypher sirolimus-eluting stent in an unselected patient population.
A comparison of the long-term safety and clinical effectiveness of the Xience V everolimus-eluting stent to both the Taxus paclitaxel-eluting stent and the Cypher sirolimus-eluting stent in an unselected patient population.
A comparison of the long-term...
05/21/2014
Journal of Invasive Cardiology
Original Contribution
02/25/2018
We investigated 477 patients who underwent TAVR and divided subjects into two groups according to malignancy status. We found that mere history of malignancy among elderly patients does not adversely affect outcomes after TAVR; however,...
We investigated 477 patients who underwent TAVR and divided subjects into two groups according to malignancy status. We found that mere history of malignancy among elderly patients does not adversely affect outcomes after TAVR; however,...
We investigated 477 patients who...
02/25/2018
Journal of Invasive Cardiology
Original Contribution
01/12/2024
The study's aim was to evaluate the added value of invasive hemodynamic assessment in patients with unexplained shortness of breath (SOB) undergoing echocardiographic assessment using the most accepted echocardiographic definition of...
The study's aim was to evaluate the added value of invasive hemodynamic assessment in patients with unexplained shortness of breath (SOB) undergoing echocardiographic assessment using the most accepted echocardiographic definition of...
The study's aim was to evaluate...
01/12/2024
Journal of Invasive Cardiology
Original Contribution
04/01/2022
The Medtronic Evolut Pro valve (EPV) is a new-generation self-expanding valve (SEV), particularly designed to reduce paravalvular leak (PVL) rates in transcatheter aortic valve replacement (TAVR). We aimed to compare the safety and efficacy...
The Medtronic Evolut Pro valve (EPV) is a new-generation self-expanding valve (SEV), particularly designed to reduce paravalvular leak (PVL) rates in transcatheter aortic valve replacement (TAVR). We aimed to compare the safety and efficacy...
The Medtronic Evolut Pro valve...
04/01/2022
Journal of Invasive Cardiology
Outcomes of Patients Turned Down for Percutaneous Mitral Valve Repair
Original Contribution
11/01/2020
Percutaneous mitral valve repair is an alternative treatment for high-risk patients with symptomatic mitral regurgitation. Our study aimed to assess the reasons for and outcomes of patients who were declined MitraClip implantation and compare...
Percutaneous mitral valve repair is an alternative treatment for high-risk patients with symptomatic mitral regurgitation. Our study aimed to assess the reasons for and outcomes of patients who were declined MitraClip implantation and compare...
Percutaneous mitral valve repair...
11/01/2020
Journal of Invasive Cardiology